Archana Maniar, M.D.

Archana Maniar, M.D.


Infectious Diseases

Internal Medicine


Internal Medicine


  • Associate Professor of Medicine
To see if Archana Maniar is accepting new patients, or for assistance finding a UC Davis doctor, please call 800-2-UCDAVIS (800-282-3284).

Lawrence J. Ellison Ambulatory Care Center

4860 Y St., Suite 0101
Sacramento, CA 95817
Driving Directions

Primary Phone:

VA Northern CA Health Care System

10535 Hospital Way
Mather, CA 95655
Driving Directions

Primary Phone:

Additional Phone Numbers

Physician Referrals: 800-4-UCDAVIS (800-482-3284)

Philosophy of Care

In a time of ever-increasing use of technology in healthcare, infectious diseases requires more than diagnostic testing and procedures. The practice of Infectious Diseases requires detailed discussions with patients and time spent understanding the course of their disease processes. 

Clinical Interests

Dr. Maniar’s clinical work includes the spectrum of infectious diseases from HIV and hepatitis C to infections in travelers and hospital-acquired infections. She sees patients in the ambulatory care and inpatient settings.

Research/Academic Interests

In addition to her clinical role, Dr. Maniar is head of Infection Control at VA Northern California Healthcare System.  She participates in antimicrobial stewardship program to encourage the appropriate use of antibacterials. 


Infectious Diseases


M.D., UC Davis School of Medicine, Sacramento CA 2000

B.A./B.S., UCLA, Los Angeles CA 1996


Internal Medicine, UC Davis Medical Center, Sacramento CA 2000-2003


Infectious Diseases, UC Davis Medical Center, Sacramento CA 2003-2005

Board Certifications

American Board of Internal Medicine, 2003

American Board of Internal Medicine, Infectious Disease, 2006

Professional Memberships

Infectious Disease Society of America

Select Recent Publications

Sharon VR, Kim J, Sudhakar S, Fung MA, Maniar A. Disseminated cutaneous sporotrichosis.  Lancet Infect Dis. 2013 Jan;13(1):95.

Ludwig A, Sato K, Schirmer P, Maniar A, Lucero-Obusan C, Fleming C, Ryono R, Oda G, Winters M, Holodniy M.  Concurrent outbreaks with co-infection of norovirus and Clostridium difficile in a long-term-care facility.  Epidemiol Infect. 2013 Feb 22:1-6. 

Maniar A, Ellis C, Asmuth D, Pollard R, Rutledge J.  HIV infection and atherosclerosis: beyond traditional risk factors. Eur J Prev Cardiol 2013 Oct;(20):720-728.

Ellis CL, Ma Z-M, Maniar AH, Mann SK, Overman HA, Li CS, Yotter T, Knight TH, Miller CJ, Pollard RB, Rutledge JC, Asmuth DM. Application of 16S ribosomal RNA gene-targeted pyrosequencing to investigate the consequence of HIV-disease and antiviral therapy on the gut microbiome: a microbial (meta)genomic snapshot of duodenal biopsies, luminal aspirates, and stool pre- and post-treatment. Antiviral Therapy  2011; 16 Suppl 2

Ellis CL, Ma ZM, Mann SK, Li CS, Wu J, Knight TH, Yotter T, Hayes TL, Maniar AH, Troia-Cancio PV, Overman HA, Torok NJ, Albanese A, Rutledge JC, Miller CJ, Pollard RB, Asmuth DM.  Molecular Characterization of Stool Microbiota in HIV-Infected Subjects by Panbacterial and Order-Level 16S Ribosomal DNA (rDNA) Quantification and Correlations with Immune Activation. J Acquir Immune Defic Syndr  2011 March 23; epub.